Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) Invested Capital (2016 - 2025)

SRx Health Solutions' Invested Capital history spans 15 years, with the latest figure at $907000.0 for Q3 2025.

  • For Q3 2025, Invested Capital rose 101.76% year-over-year to $907000.0; the TTM value through Sep 2025 reached $907000.0, up 101.76%, while the annual FY2025 figure was $907000.0, N/A changed from the prior year.
  • Invested Capital reached $907000.0 in Q3 2025 per SRXH's latest filing, up from -$41.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $73.1 million in Q3 2021 to a low of -$61.3 million in Q4 2024.
  • Average Invested Capital over 5 years is $12.3 million, with a median of $9.2 million recorded in 2025.
  • Peak YoY movement for Invested Capital: surged 3669.65% in 2022, then plummeted 2070.34% in 2024.
  • A 5-year view of Invested Capital shows it stood at $68.1 million in 2021, then crashed by 51.68% to $32.9 million in 2022, then plummeted by 90.56% to $3.1 million in 2023, then tumbled by 2070.34% to -$61.3 million in 2024, then skyrocketed by 101.48% to $907000.0 in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Invested Capital are $907000.0 (Q3 2025), -$41.8 million (Q2 2025), and $9.2 million (Q1 2025).